Your partner in precision gene therapy
INSPIRED BY NATURE - MOTIVATED BY HEALTH
At rAAVen Therapeutics we are driven by our curiosity and dedication. We want to help pave the way for Next generation of gene therapies. At rAAVen we have the expertise and commitment to generate novel AAV capsids that can be used to tackle a wide array of disorders. Using state of the art methodologies within cloning, virus variant production and sequencing, we build novel viral vectors for precision targeting of defined cell populations or with desired properties.
Research
Vector Engineering
Generating the next generation of viral vectors with refined cell targeting and desirable properties.
Respiratory Disease
By refining targeting of viral vectors we seek to enable future therapies for respiratory diseases.
Neurodegeneration
The brain is the most complex organ in the body. By designing vector and cell interactions we set out to provide a toolbox for a range of brain targeted gene therapies.
Leadership
Per Wilander
Chief Executive Officer
Marcus Davidsson
Founder, Chief Operating Officer
Alexander Svanbergsson
Founder, Chief Scientific Officer